February 4, 2014
Studying the Genomics of Antiplatelet Heart Medication
By Center for Individualized Medicine
Which antiplatelet medication is best after a coronary stent? The answer may lie in your genes, but heart experts differ with the Food and Drug Administration on when to do genotype testing on angioplasty patients and whether genetic testing will keep heart patients out of the emergency rooms. Around 600,000 angioplasties are performed every year in the United […]
Tags: angioplasties, angioplasty, antiplatelet medication, Brilinta, Center for Individualized Medicne, DNA Sequencing, individualized medicine, Personal Care, Personal Medicine, pharmacogenomics, Plavix, TAILOR
December 26, 2013
Genomics: Making Science Fiction a Reality
Article originally posted on Discovery’s Edge. Genetic research first intrigued pharmacologist Richard Weinshilboum, M.D., of Mayo Clinic in Rochester, Minn., more than 30 years ago, when he began painstaking biochemistry techniques in his Pharmacogenomics Laboratory. As Dr. Weinshilboum’s research team studied enzymes involved in eliminating neurotransmitters, they discovered a related enzyme, known as TPMT, that eliminated a […]
Tags: beauty project, cancer, center for individualized medicine, gene sequencing, genetic, genetic test, Genetics, genome, Genome Sequencing, Genomic, genomics, Gianrico Farrugia
October 17, 2013
Discovering Smoker’s Lung Cancer Biomarker
By AJ Montpetit
Researchers at Mayo Clinic recently found that a specific pair of proteins may be a successful prognostic biomarker for identifying smoking-related lung cancers. The clinical significance of neuroendocrine (NE) differentiation in lung adenocarcinoma (AD), and the most appropriate biomarkers for this assessment, has long been debated. In the absence of a gold standard, investigators have most […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, George Vasmatzis, Lung Cancer, Personal Care, Personal Medicine, personalized care, personalized medicine, Smoke, Smoker